Body composition in kids on growth hormone
Part of Hormones & metabolism clinical trials.
This study looks at how growth hormone treatment affects body composition (fat and muscle) in children with growth hormone deficiency. It may help doctors better understand and monitor treatment effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 3 and 17 years old.
- You have been diagnosed with growth hormone deficiency.
- Your doctor has prescribed growth hormone treatment (daily or long-acting).
- You have not started growth hormone yet, or you are already on it and want to switch to a different form.
- You and your parents agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how different types of growth hormone treatment affect growth and metabolism in children with growth hormone deficiency. It helps compare standard treatment with a long-acting type and looks at growth and metabolic changes.
This study looks at how the body’s growth signals (growth hormone and related proteins) work in children. It may help researchers understand growth differences in kids who are healthy or have certain growth-related conditions.
This study follows adults who had growth hormone deficiency as children and are now part of a research registry. It aims to understand their health outcomes as they transition into adulthood.
This trial tests an oral medication called GS3-007a for children who have not yet reached puberty and have growth hormone deficiency. The goal is to see if it helps them grow taller.
This study tests a new growth hormone treatment called GenSci134 for children who have not yet gone through puberty and are not growing because their bodies do not make enough growth hormone. The goal is to see if the medicine helps them grow taller.
This trial tests a new growth hormone treatment called GenSci134 in healthy adults and adults with growth hormone deficiency (AGHD). The goal is to see if it is safe and effective for people who need growth hormone replacement.
Hear when a new Isolated Non-acquired Growth Hormone Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.